Castle PE - Search Results

1

Associations of Obesity with Post-Treatment Risks of Cervical Precancer and Cancer.

Clarke MA, Befano B, Wentzensen N, Cheung LC, Egemen D, Castle PE, Schiffman M, Goldhoff PE, Seo TS, Suh-Burgmann EJ, Poitras N, Fuller LA, Wi S, Lorey T, Shah NR. Clarke MA, et al. Among authors: castle pe. Am J Obstet Gynecol. 2024 Dec 6:S0002-9378(24)01179-7. doi: 10.1016/j.ajog.2024.12.002. Online ahead of print. Am J Obstet Gynecol. 2024. PMID: 39647654

2

Hybrid capture 2 viral load and the 2-year cumulative risk of cervical intraepithelial neoplasia grade 3 or cancer.

Castle PE, Schiffman M, Wheeler CM. Castle PE, et al. Am J Obstet Gynecol. 2004 Nov;191(5):1590-7. doi: 10.1016/j.ajog.2004.05.018. Am J Obstet Gynecol. 2004. PMID: 15547529

3

Relationship of atypical glandular cell cytology, age, and human papillomavirus detection to cervical and endometrial cancer risks.

Castle PE, Fetterman B, Poitras N, Lorey T, Shaber R, Kinney W. Castle PE, et al. Obstet Gynecol. 2010 Feb;115(2 Pt 1):243-248. doi: 10.1097/AOG.0b013e3181c799a3. Obstet Gynecol. 2010. PMID: 20093895

4

The age-specific relationships of abnormal cytology and human papillomavirus DNA results to the risk of cervical precancer and cancer.

Castle PE, Fetterman B, Thomas Cox J, Shaber R, Poitras N, Lorey T, Kinney W. Castle PE, et al. Obstet Gynecol. 2010 Jul;116(1):76-84. doi: 10.1097/AOG.0b013e3181e3e719. Obstet Gynecol. 2010. PMID: 20567171

5

Variable risk of cervical precancer and cancer after a human papillomavirus-positive test.

Castle PE, Fetterman B, Poitras N, Lorey T, Shaber R, Schiffman M, Demuth F, Kinney W. Castle PE, et al. Obstet Gynecol. 2011 Mar;117(3):650-656. doi: 10.1097/AOG.0b013e318209da59. Obstet Gynecol. 2011. PMID: 21343769

6

Invasive Cervical Cancer After a Positive Pap Test Result and Negative Human Papillomavirus Test Result.

Locke A, Shah NR, Fetterman B, Poitras N, Wi S, Castle PE, Wentzensen N, Kinney W, Clarke MA, Lorey T. Locke A, et al. Among authors: castle pe. Obstet Gynecol. 2021 Oct 1;138(4):580-581. doi: 10.1097/AOG.0000000000004543. Obstet Gynecol. 2021. PMID: 34623071 Free PMC article.

7

Calendar-period trends in cervical precancer and cancer diagnoses since the introduction of human papillomavirus and cytology co-testing into routine cervical cancer screening at Kaiser Permanente Northern California.

Befano B, Wentzensen N, Lorey T, Poitras N, Cheung LC, Schiffman M, Clarke MA, Cohen C, Kinney W, Locke A, Castle PE. Befano B, et al. Among authors: castle pe. Gynecol Oncol. 2024 May;184:89-95. doi: 10.1016/j.ygyno.2024.01.038. Epub 2024 Jan 31. Gynecol Oncol. 2024. PMID: 38301311

8

Risk of precancer and follow-up management strategies for women with human papillomavirus-negative atypical squamous cells of undetermined significance.

Safaeian M, Solomon D, Wacholder S, Schiffman M, Castle P. Safaeian M, et al. Obstet Gynecol. 2007 Jun;109(6):1325-31. doi: 10.1097/01.AOG.0000263461.71732.40. Obstet Gynecol. 2007. PMID: 17540804 Clinical Trial.

9

Diagnostic utility of endocervical curettage in women undergoing colposcopy for equivocal or low-grade cytologic abnormalities.

Solomon D, Stoler M, Jeronimo J, Khan M, Castle P, Schiffman M. Solomon D, et al. Obstet Gynecol. 2007 Aug;110(2 Pt 1):288-95. doi: 10.1097/01.AOG.0000270154.69879.09. Obstet Gynecol. 2007. PMID: 17666602 Clinical Trial.

10

Risk assessment to guide the prevention of cervical cancer.

Castle PE, Sideri M, Jeronimo J, Solomon D, Schiffman M. Castle PE, et al. Am J Obstet Gynecol. 2007 Oct;197(4):356.e1-6. doi: 10.1016/j.ajog.2007.07.049. Am J Obstet Gynecol. 2007. PMID: 17904958 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

506 results

Search Page

Filters